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Topical microbicides that reduce or eliminate the risk of
human immunodeficiency virus type 1 (HIV-1) sexual
transmission must function effectively within the cervi-
covaginal environment where multiple factors may
impact the efficacy of the active agent. Factors relevant to
potential changes in microbicide efficacy include the pres-
ence of mucins within the cervical mucus. We hypothesize
that polycationic PEHMB molecules will interact with the
anionic mucin molecules to form a lattice-like network
that serves as a physical barrier to the movement of infec-
tious virus and HIV-1-infected cells to the cervical and
vaginal epithelia. In vitro experiments demonstrated that
the anti-HIV-1 activity of PEHMB was increased almost
two logs in the presence of mucin. In contrast, the activity
of anionic dextran sulfate was unaffected. These results
suggest that electrostatic interactions between PEHMB
and mucin molecules may augment the inherent anti-
HIV-1 activity of PEHMB by facilitating the formation of a
physical barrier between HIV-1 and susceptible cells. This
property would be expected to increase the in vivo efficacy
of PEHMB.
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